Yes it seems this board is consumed by an uncertainty planted by AF. The more impactful company changing events of German revenue and ASCO / Direct hints of encouragements are not mentioned much now.
Linda said that the phase 3 trial in Europe is being expanded to several new centers of excellence and they they would not join a trial that is in trouble, has serious problem, so I remain steady and determined. Linda has performed at every turn, with positive surprises...: finances, EU, accelerating revenues!, Direct results encouraging!, and trial progression.
I think many questions on this "uncertainty" get answered in a week or so with a DMC recommendation on efficacy, so let's be patient and wait.
News 
Market Data 
Discover 
